Terms: = Germ cell tumor AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
1837 results:
1. Laser interstitial thermal therapy for recurrent glioblastomas: a systematic review and meta-analysis.
Zhao X; Li R; Guo Y; Wan H; Zhou D
Neurosurg Rev; 2024 Apr; 47(1):159. PubMed ID: 38625588
[TBL] [Abstract] [Full Text] [Related]
2. Uveal melanoma cell lines Mel270 and 92.1 exhibit a mesenchymal phenotype and sensitivity to the cytostatic effects of transforming growth factor beta in vitro.
Doudnikoff C; Leclerc D; Angenard G; Gilot D; Coulouarn C; Mouriaux F
Mol Vis; 2024; 30():160-166. PubMed ID: 38601020
[TBL] [Abstract] [Full Text] [Related]
3. Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis.
Tsuchiya T; Ikemura M; Miyawaki S; Teranishi Y; Ohara K; Ushiku T; Saito N
Brain Tumor Pathol; 2024 Apr; 41(2):73-79. PubMed ID: 38578531
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of preoperative diffusion restriction in glioblastoma.
Labbène E; Mahmoud M; Marrakchi-Kacem L; Ben Hamouda M
Tunis Med; 2024 Feb; 102(2):94-99. PubMed ID: 38567475
[TBL] [Abstract] [Full Text] [Related]
5. Advancing glioma diagnosis: Integrating custom U-Net and VGG-16 for improved grading in MR imaging.
Saluja S; Trivedi MC; Sarangdevot SS
Math Biosci Eng; 2024 Feb; 21(3):4328-4350. PubMed ID: 38549330
[TBL] [Abstract] [Full Text] [Related]
6. Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial.
Schadendorf D; Luke JJ; Ascierto PA; Long GV; Rutkowski P; Khattak A; Del Vecchio M; de la Cruz-Merino L; Mackiewicz J; Sileni VC; Kirkwood JM; Robert C; Grob JJ; Dummer R; Carlino MS; Zhao Y; Kalabis M; Krepler C; Eggermont A; Scolyer RA
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485189
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of
Ramakrishnan D; Brüningk SC; von Reppert M; Memon F; Maleki N; Aneja S; Kazerooni AF; Nabavizadeh A; Lin M; Bousabarah K; Molinaro A; Nicolaides T; Prados M; Mueller S; Aboian MS
AJNR Am J Neuroradiol; 2024 Apr; 45(4):475-482. PubMed ID: 38453411
[TBL] [Abstract] [Full Text] [Related]
8. Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G; Fabricio ASC; Del Bianco P; Salizzato V; Favaretto A; Piccin L; Zustovich F; Fabozzi A; De Rossi C; Pigozzo J; De Nuzzo M; Cappelletto E; Bonanno L; Palleschi D; De Salvo GL; Guarneri V; Gion M; Chiarion-Sileni V
J Transl Med; 2024 Mar; 22(1):242. PubMed ID: 38443899
[TBL] [Abstract] [Full Text] [Related]
9. Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study.
Rastogi A; Brugnara G; Foltyn-Dumitru M; Mahmutoglu MA; Preetha CJ; Kobler E; Pflüger I; Schell M; Deike-Hofmann K; Kessler T; van den Bent MJ; Idbaih A; Platten M; Brandes AA; Nabors B; Stupp R; Bernhardt D; Debus J; Abdollahi A; Gorlia T; Tonn JC; Weller M; Maier-Hein KH; Radbruch A; Wick W; Bendszus M; Meredig H; Kurz FT; Vollmuth P
Lancet Oncol; 2024 Mar; 25(3):400-410. PubMed ID: 38423052
[TBL] [Abstract] [Full Text] [Related]
10. Assessment of Social Vulnerabilities of Care and Prognosis in Adult Ocular Melanomas in the US.
Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
[TBL] [Abstract] [Full Text] [Related]
11. The causal relationship between gut microbiota and neuroblastoma: a bidirectional Mendelian randomization analysis and meta-analysis.
Zhang Z; Li D; Xie F; Zhang H
Microbiol Spectr; 2024 Apr; 12(4):e0365623. PubMed ID: 38411074
[TBL] [Abstract] [Full Text] [Related]
12. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a systematic review and meta-analysis.
Szymoniuk M; Kochański M; Wilk K; Miazga D; Kanonik O; Dryla A; Kamieniak P
Acta Neurochir (Wien); 2024 Feb; 166(1):101. PubMed ID: 38393397
[TBL] [Abstract] [Full Text] [Related]
13. An adult with recurrent atypical teratoid rhabdoid tumor of the spine.
Charles AJ; Smith VL; Goodwin CR; Johnson MO
CNS Oncol; 2024 Jan; 13(1):CNS105. PubMed ID: 38380555
[TBL] [Abstract] [Full Text] [Related]
14. Neuroendocrine neoplasms of the gallbladder: A single institute analysis of outcomes and prognostic factors.
Nandy K; Patkar S; Yadav S; Ostwal V; Ramaswamy A; Bhargav P; Goel M
J Surg Oncol; 2024 May; 129(6):1121-1130. PubMed ID: 38348696
[TBL] [Abstract] [Full Text] [Related]
15. Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
Tang JD; Mills MN; Nakashima J; Dohm AE; Khushalani NI; Forsyth PA; Vogelbaum MA; Wuthrick EJ; Yu HM; Oliver DE; Liu JKC; Ahmed KA
J Neurooncol; 2024 Feb; 166(3):431-440. PubMed ID: 38310157
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy.
Taylor AM; McKeown J; Dimitriou F; Jacques SK; Zimmer L; Allayous C; Yeoh HL; Haydon A; Ressler JM; Galea C; Woodford R; Kahler K; Hauschild A; Festino L; Hoeller C; Schwarze JK; Neyns B; Wicky A; Michielin O; Placzke J; Rutkowski P; Johnson DB; Lebbe C; Dummer R; Ascierto PA; Lo S; Long GV; Carlino MS; Menzies AM
Eur J Cancer; 2024 Mar; 199():113561. PubMed ID: 38278009
[TBL] [Abstract] [Full Text] [Related]
17. Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy.
Jacques SK; McKeown J; Grover P; Johnson DB; Zaremba A; Dimitriou F; Weiser R; Farid M; Namikawa K; Sullivan RJ; Rutkowski P; Lebbe C; Hamid O; Zager JS; Michielin O; Neyns B; Nakamura Y; Robert C; Mehnert J; Ascierto PA; Bhave P; Park B; Zimmer L; Mangana J; Mooradian M; Placzke J; Allayous C; Glitza Oliva IC; Mehmi I; Depalo D; Wicky A; Schwarze JK; Roy S; Boatwright C; Vanella V; Long GV; Menzies AM; Lo SN; Carlino MS
Eur J Cancer; 2024 Mar; 199():113563. PubMed ID: 38278007
[TBL] [Abstract] [Full Text] [Related]
18. Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
Mandalà M; Lorigan P; Sergi MC; Benannoune N; Serra P; Vitale MG; Giannarelli D; Arance AM; Couselo EM; Neyns B; Tucci M; Guida M; Spagnolo F; Rossi E; Occelli M; Queirolo P; Quaglino P; Depenni R; Merelli B; Placzke J; Di Giacomo AM; Del Vecchio M; Indini A; da Silva IP; Menzies AM; Long GV; Robert C; Rutkowski P; Ascierto PA
Eur J Cancer; 2024 Mar; 199():113542. PubMed ID: 38266540
[TBL] [Abstract] [Full Text] [Related]
19. Gamma Knife radiosurgery for central neurocytoma: a quantitative systematic review and metanalysis.
Spina A; Garbin E; Albano L; Bisoglio A; Boari N; Mortini P
Neurosurg Rev; 2024 Jan; 47(1):64. PubMed ID: 38265530
[TBL] [Abstract] [Full Text] [Related]
20. MRI treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis.
Müller SJ; Khadhraoui E; Ganslandt O; Henkes H; Gihr GA
J Neurooncol; 2024 Feb; 166(3):513-521. PubMed ID: 38261142
[TBL] [Abstract] [Full Text] [Related]
[Next]
